Atlas Trials

MB-CART19.1 in Patients With R/R ALL

Clinical trial NCT03321123 · UNKNOWN

Trial details

NCT number
NCT03321123
Sponsor
Shanghai Children's Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory
Start date
2017-12-01
Primary completion
2019-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.